Proactive Investors - Run By Investors For Investors

Fastnet looks for biotech investments after direction shift

Fastnet had US$15.9mln of cash at the end of July.
Fastnet looks for biotech investments after direction shift
The healthcare industry, particularly the biopharma sector, is experiencing strong momentum.

Fastnet Equity (LON:FAST) has drawn a line under its oil and gas business as it looks for healthcare businesses to acquire.

The company announced the change of direction last month after it struggled to find partners for its hydrocarbon assets in the Celtic Sea and Morocco.

Fastnet has now withdrawn from its involvement in the Foum Assaka Licence, Offshore Morocco and is considering the options for the Irish assets, which may include spinning them off in to a stand-alone entity.

Cash at the end of July was US$15.9mln, while admin costs were down to US$1.9mln per year though the target is to get this down to under US$600,000.

Cathal Friel, chairman, said:The board believes that the healthcare industry, particularly the biopharma sector, is experiencing strong momentum and there exist significant M&A and value creation opportunities for both small cap and large cap companies.

“Furthermore, the board believes that it has access to an international pipeline of such opportunities that could lead to value creation for Fastnet's shareholders.”

Latest figures for the year to March showed an annual loss of US$39.7mln the bulk of which was accounted for by impairments of US$36.6mln for its oil and gas assets.

View full AMYT profile View Profile

Amryt Pharma PLC Timeline

Related Articles

scientist in lab
December 20 2018
Data from Midatech's MTD201 drug has validated the company's Q-Sphera sustained release technology, and other, bigger players are starting to sit up and take note
Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system
October 17 2018
The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO whose stake is more than just business as usual

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use